Open access · OA
via Europe PMC
The Epigenetic Aging-Cancer Continuum: Biomarkers, Metabolism, and Therapy.
Papaneophytou C, Pieri M, Makreli ME, Charidemou E, Andreou EP.
Genes · 2026
Abstract
Aging and cancer form a biological continuum influenced by epigenomic changes, metabolic dysfunction, inflammation, cellular senescence(definition), and loss of tissue homeostasis. Age-related epigenetic alterations can promote cancer, which exploits plasticity for evolution, immune evasion, metastasis, and resistance. Nutrition and metabolism affect this process through one-carbon metabolism, methyl-donor availability, acetyl-CoA and NAD<sup>+</sup> balance, redox status, microbiome metabolites, and chromatin enzyme activity. Circulating biomarkers such as cell-free DNA methylation, mutation-based ctDNA, fragmentomic features, and non-coding RNAs can detect tumor and host changes linked to aging, inflammation, nutrition, and treatment with minimal invasiveness. This review explores the epigenetic aging-cancer link, how nutrition and metabolism modify pathways, and the potential of circulating biomarkers for diagnosis, prognosis, prediction, and monitoring. The focus is on epigenetic plasticity, drug-tolerant states, resistance, epigenetic drugs, metabolic targeting, and nutritional interventions. New technologies, including single-cell and spatial epigenomics, long-read sequencing, and multimodal computational approaches, aid biomarker discovery and clinical use. Challenges include variability, misclassification, heterogeneity, confounding, reverse causality, overfitting, and limited validation. Clinical applications need standard workflows, representative cohorts, transparent models, and proof that biomarker-guided strategies improve outcomes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3390/genes17091130
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
C, P., M, P., ME, M., E, C., & EP., A. (2026). The Epigenetic Aging-Cancer Continuum: Biomarkers, Metabolism, and Therapy. <em>Genes</em>. https://doi.org/10.3390/genes17091130
Vancouver
C P, M P, ME M, E C, EP. A. The Epigenetic Aging-Cancer Continuum: Biomarkers, Metabolism, and Therapy. Genes. 2026. doi:10.3390/genes17091130.
BibTeX
@article{papaneophytou2026TheEpi,
title = {The Epigenetic Aging-Cancer Continuum: Biomarkers, Metabolism, and Therapy.},
author = {Papaneophytou C and Pieri M and Makreli ME and Charidemou E and Andreou EP.},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17091130},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Healthy ageing and longevity 2019
Citation only
Epigenetic Biomarkers of Aging
Cells 2024
Open access · CC-BY
Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?
Genome Medicine 2021
Open access · CC-BY
Epigenetic signatures in cancer: proper controls, current challenges and the potential for clinical translation
Nature Aging 2024
Preprint · CC-BY
ImAge quantitates aging and rejuvenation
Signal transduction and targeted therapy 2026
Open access · OA
Aging and cancer: current understandings and future perspectives.
Frontiers in Immunology 2026
Open access · CC-BY